Transplant Genomics

About:

Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes.

Website: https://trugraf.com/

Twitter/X: trugraf

Description:

Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes with noninvasive serial monitoring guided by genomics. Its extensive development pipeline includes diagnostic and predictive tests for kidney and liver graft dysfunction, the use of multiple sample types and technology platforms, companion diagnostics for immune suppressants and immune status tests.

Total Funding Amount:

$6.21M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woodland Hills, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)transplantgenomics.com

Founders:

Daniel Salomon, Stanley D. Rose

Number of Employees:

1-10

Last Funding Date:

2014-11-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai